WebList of products in the National Drug Code with proprietary name koate. This medication is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. People with low factor VIII levels are at risk for bleeding longer after an injury ... WebKOATE. QTY 1 • 500 (+/-) • VIAL • Near 77381. Add to Medicine Chest. Set Price Alert. ANTIHEMOPHILIC FACTOR (AHF or FACTOR VIII) (an tee hee moe FIL ik fak tir) is used to …
Side Effects of Koate (Antihemophilic Factor), Warnings, …
WebSep 1, 2024 · Note: The cumulative amount of medication the patient has on-hand will be taken into account for authorizations. Up to 5 ‘on-hand’ doses for the treatment of acute bleeding episodes will be ... Koate DVI: 55,200 billable units per 28 day supply Recombinate: 55,200 billable units per 28 day supply . Page 2 FACTOR VIII_HEMOPHILIA PRODUCTS ... WebOct 12, 2024 · nausea, vomiting, upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes). Common side effects may include: … marriott salesforce.com
Koate Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
WebCertain AHF products (Alphanate, Humate-P, Koate-HP, and Koate-DVI) in large and/or frequent doses in patients with A, B, or AB blood types may result in intravascular hemolysis and hemolytic anemia. Should this occur, consider the administration of serologically compatible type O red blood cells or the administration of AHF produced from group ... WebApr 1, 2024 · Antihemophilic factor (AHF) is a protein that is produced naturally in the body. It helps the blood form clots to stop bleeding and prevents bleeding problems from happening as often. Hemophilia A, also called classical hemophilia, is a condition where the body does not make enough AHF. If you do not have enough AHF and you become injured, … WebKoate: Administer at a rate not to exceed 10 mL/minute; adapt the rate to the individual patient's response.[61730] Koate-DVI: Administer over 5 to 10 minutes.[56365] Kovaltry: Administer over 1 to 15 minutes; adapt the rate to the individual patient's response.[60650] Monoclate-P: Administer at a rate of approximately 2 mL/minute.[56326] marriott rosemont